Moreover, KLK5 targets a broad range of substrates such as insulin-like growth factor binding proteins, transforming growth factor (TGF-β), and protease-activated receptors (PAR), which upon (in-)activation by KLK5 modulate important tumor-associated signaling pathways [39, 40]. This evidence concerns the gene TGFB1 and neoplasm.